To include your compound in the COVID-19 Resource Center, submit it here.
RNA exon skipping drug company Skyhawk Therapeutics Inc. (Waltham, Mass.) debuted Tuesday with $8
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury